4DMedical Limited
FDMDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.21B
Close$
$-0.01
100.7% downside
Current Fair Value
100.7% downsideOvervalued by 100.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.21 Billion |
|---|---|
| Enterprise Value | $1.94 Billion |
| Earnings per Share | $-0.39 |
| Beta | 1.97 |
| Outstanding Shares | 597,328,000 |
Return
| Return on Equity | -137.93% |
|---|---|
| Return on Assets | -64.24% |
| Return on Invested Capital | -29.52% |
Valuation & Multiples
| P/E Ratio | -9.31 |
|---|---|
| PEG | -2.58 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 150.04 |
| Enterprise Value to EBIT | -18.46 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$5.24 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$6.26 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About 4DMedical Limited
181 employees
CEO: Andreas Fouras
Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Tec...